Eli Lilly Gets US FDA Nod For Once-Weekly Onswik Insulin For Type 2 Diabetes
Eli Lilly has secured US Food and Drug Administration approval for Onswik (insulin efsitora alfa-gobe), a once-weekly basal insulin injection for adults with type 2 diabetes, adding a dosing option to its diabetes portfolio. The approval covers Onswik for use alongside diet and exercise to improve blood sugar control. Lilly said the treatment is designed…